Search Results

There are 8544 results for: content related to: Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: Results of two preclinical and phase II randomized control studies

  1. Effects of interleukin-10 on cutaneous wounds and scars in humans of African continental ancestral origin

    Wound Repair and Regeneration

    Volume 22, Issue 3, May-June 2014, Pages: 326–333, Ingrid Kieran, Catherine Taylor, Jim Bush, Mark Rance, Karen So, Adam Boanas, Anthony Metcalfe, Rosalind Hobson, Nick Goldspink, John Hutchison and Mark Ferguson

    Version of Record online : 20 MAY 2014, DOI: 10.1111/wrr.12178

  2. Kinetic study of recombinant human protein disulphide isomerase-assisted C125A recombinant human interleukin-2 folding

    Biotechnology and Applied Biochemistry

    Volume 37, Issue 2, April 2003, Pages: 129–138, Chengan Du and Janet L. Wolfe

    Version of Record online : 23 DEC 2010, DOI: 10.1042/BA20020057

  3. A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 6, June 2005, Pages: 649–658, Dr Caroline Trudeau, Dr Monette M. Cotreau, Ms Lucille Stonis, Dr Kevin H. Dykstra, Ms Judy L. Oestreicher, Dr Andrew Strahs, Dr Andrew J. Dorner, Dr Victor H. Van Cleave, Dr William L. Trepicchio and Dr Ullrich S. Schwertschlag

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005276116

  4. You have full text access to this Open Access content
    A novel platform for biologically active recombinant human interleukin-13 production

    Plant Biotechnology Journal

    Volume 6, Issue 5, June 2008, Pages: 504–515, David J. Wang, Martin Brandsma, Ziqin Yin, Aiming Wang, Anthony M. Jevnikar and Shengwu Ma

    Version of Record online : 3 APR 2008, DOI: 10.1111/j.1467-7652.2008.00337.x

  5. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide

    European Journal of Neuroscience

    Volume 28, Issue 12, December 2008, Pages: 2499–2510, J. P. Konsman, J. Veeneman, C. Combe, S. Poole, G. N. Luheshi and R. Dantzer

    Version of Record online : 9 DEC 2008, DOI: 10.1111/j.1460-9568.2008.06549.x

  6. A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease

    Haemophilia

    Volume 14, Issue 5, September 2008, Pages: 968–977, M. V. RAGNI, R. C. JANKOWITZ, H. L. CHAPMAN, E. P. MERRICKS, M. T. KLOOS, A. M. DILLOW and T. C. NICHOLS

    Version of Record online : 1 AUG 2008, DOI: 10.1111/j.1365-2516.2008.01827.x

  7. You have free access to this content
    Interleukin-10-induced CD8 cell proliferation

    Immunology

    Volume 98, Issue 1, September 1999, Pages: 80–89, Rowbottom, Lepper, Garland, Cox, Corley, Oakhill and Steward

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2567.1999.00828.x

  8. You have free access to this content
    Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy

    Cancer

    Volume 97, Issue 12, 15 June 2003, Pages: 3099–3106, Scott B. Cantor, Linda S. Elting, David V. Hudson Jr. and Edward B Rubenstein

    Version of Record online : 29 MAY 2003, DOI: 10.1002/cncr.11447

  9. Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model

    British Journal of Dermatology

    Volume 160, Issue 2, February 2009, Pages: 284–296, K. Stenderup, C. Rosada, A. Worsaae, F. Dagnaes-Hansen, T. Steiniche, E. Hasselager, L.F. Iversen, S. Zahn, H. Wöldike, H. Lindgreen Holmberg, J. Rømer, K. Kragballe, J.T. Clausen and T.N. Dam

    Version of Record online : 20 OCT 2008, DOI: 10.1111/j.1365-2133.2008.08890.x

  10. Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist

    Journal of Pharmaceutical Sciences

    Volume 84, Issue 5, May 1995, Pages: 575–580, Dong-Chool Kim, Barbara Reitz, David F. Carmichael and Duane C. Bloedow

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600840511

  11. You have full text access to this Open Access content
    Production of biologically active human interleukin-4 in transgenic tobacco and potato

    Plant Biotechnology Journal

    Volume 3, Issue 3, May 2005, Pages: 309–318, Shengwu Ma, Yan Huang, Antonelle Davis, Ziqin Yin, Qingsheng Mi, Rima Menassa, James E. Brandle and Anthony M. Jevnikar

    Version of Record online : 1 APR 2005, DOI: 10.1111/j.1467-7652.2005.00125.x

  12. Recombinant human interleukin-3 administered concomitantly with chemotherapy in patients with relapsed small cell lung cancer

    Journal of Experimental Therapeutics and Oncology

    Volume 2, Issue 1, January/February 2002, Pages: 47–52, Bonne Biesma, Klaas W. Van Kralingen, Rob W. Van Leen, Maria C. Koster and Pieter E. Postmus

    Version of Record online : 18 MAR 2002, DOI: 10.1046/j.1359-4117.2002.01006.x

  13. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells

    Clinical & Experimental Allergy

    Volume 31, Issue 7, July 2001, Pages: 1077–1085, M. Kambe, N. Kambe, C. A. Oskeritzian, N. Schechter and L. B. Schwartz

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2222.2001.01126.x

  14. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution

    Journal of Pharmaceutical Sciences

    Volume 93, Issue 12, December 2004, Pages: 3076–3089, Ye Zhang, Shouvik Roy, Latoya S. Jones, Sampathkumar Krishnan, Bruce A. Kerwin, Byeong S. Chang, Mark C. Manning, Theodore W. Randolph and John F. Carpenter

    Version of Record online : 27 OCT 2004, DOI: 10.1002/jps.20219

  15. You have free access to this content
    Large-scale production, purification and bioactivity assay of recombinant human interleukin-6 in the methylotrophic yeast Pichia pastoris

    FEMS Yeast Research

    Volume 11, Issue 2, March 2011, Pages: 160–167, Hongbo Li, Yu Wang, Aimin Xu, Shiwu Li, Shouguang Jin and Donghai Wu

    Version of Record online : 22 DEC 2010, DOI: 10.1111/j.1567-1364.2010.00701.x

  16. Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen–deuterium exchange

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 10, October 2011, Pages: 4215–4224, John R. Alford, Andrew C. Fowler, Deborah S. Wuttke, Bruce A. Kerwin, Ramil F. Latypov, John F. Carpenter and Theodore W. Randolph

    Version of Record online : 5 MAY 2011, DOI: 10.1002/jps.22601

  17. You have free access to this content
    Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes

    Immunology

    Volume 100, Issue 1, May 2000, Pages: 63–69, N. L. Mathy, W. Scheuer, M. Lanzendörfer, K. Honold, D. Ambrosius, S. Norley and R. Kurth

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2567.2000.00997.x

  18. You have free access to this content
    Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

    British Journal of Haematology

    Volume 128, Issue 1, January 2005, Pages: 49–58, Mitchell S. Cairo, Virginia Davenport, Olga Bessmertny, Stanton C. Goldman, Stacy L. Berg, Susan G. Kreissman, Joseph Laver, Violet Shen, Rita Secola, Carmella Van De Ven and Gregory H. Reaman

    Version of Record online : 7 DEC 2004, DOI: 10.1111/j.1365-2141.2004.05281.x

  19. Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization

    Biotechnology Progress

    Volume 28, Issue 2, March/April 2012, Pages: 497–507, Vinay V. Vyas, Dominic Esposito, Terry L. Sumpter, Trevor L. Broadt, James Hartley, George C. Knapp IV, Wei Cheng, Man-Shiow Jiang, John M. Roach, Xiaoyi Yang, Steven L. Giardina, George Mitra, Jason L. Yovandich, Stephen P. Creekmore, Thomas A. Waldmann and Jianwei Zhu

    Version of Record online : 9 DEC 2011, DOI: 10.1002/btpr.746

  20. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 2, February 2005, Pages: 382–396, Shouvik Roy, Rose Jung, Bruce A. Kerwin, Theodore W. Randolph and John F. Carpenter

    Version of Record online : 21 DEC 2004, DOI: 10.1002/jps.20258